Zhonghong Pulin Medical Products Co., Ltd.
SZSE:300981.SZ
15.07 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,456.651 | 2,105.25 | 1,572.569 | 4,909.311 | 4,778.407 | 1,170.814 | 967.534 | 951.153 | 710.081 | 604.083 | 585.049 | 550.611 |
| Cost of Revenue
| 2,128.184 | 2,006.936 | 1,420.088 | 1,880.2 | 1,393.697 | 950.064 | 798.351 | 769.007 | 584.802 | 468.206 | 484.105 | 483.023 |
| Gross Profit
| 328.467 | 98.313 | 152.48 | 3,029.111 | 3,384.71 | 220.75 | 169.183 | 182.147 | 125.279 | 135.877 | 100.944 | 67.588 |
| Gross Profit Ratio
| 0.134 | 0.047 | 0.097 | 0.617 | 0.708 | 0.189 | 0.175 | 0.192 | 0.176 | 0.225 | 0.173 | 0.123 |
| Reseach & Development Expenses
| 49.704 | 31.606 | 8.832 | 21.789 | 11.649 | 9.309 | 9.233 | 1.922 | 1.358 | 1.094 | 0 | 0 |
| General & Administrative Expenses
| 29.884 | 113.117 | 22.102 | 18.016 | -26.249 | -122.92 | -124.046 | -100.944 | 9.292 | 10.561 | 8.299 | 9.138 |
| Selling & Marketing Expenses
| 52.96 | 56.432 | 56.001 | 43.469 | 20.683 | 44.647 | 32.683 | 31.084 | 31.136 | 24.688 | 23.318 | 18.241 |
| SG&A
| 82.844 | 222.472 | 78.102 | 61.485 | -5.567 | -78.273 | -91.363 | -69.86 | 40.428 | 35.249 | 31.617 | 27.379 |
| Other Expenses
| 261.657 | -18.892 | 58.407 | -3.574 | 91.732 | 68.281 | 40.27 | 100.023 | 4.27 | 2.509 | 0.457 | 3.223 |
| Operating Expenses
| 394.205 | 235.186 | 140.875 | 166.098 | 101.222 | 99.944 | 89.414 | 75.477 | 70.558 | 62.37 | 54.876 | 43.651 |
| Operating Income
| -65.737 | -136.873 | -10.995 | 2,787.86 | 3,193.241 | 106.174 | 70.376 | 86.331 | 48.312 | 51.273 | 33.169 | 0.728 |
| Operating Income Ratio
| -0.027 | -0.065 | -0.007 | 0.568 | 0.668 | 0.091 | 0.073 | 0.091 | 0.068 | 0.085 | 0.057 | 0.001 |
| Total Other Income Expenses Net
| -1.166 | -0.477 | 62.267 | -3.574 | -1.311 | -0.416 | -0.047 | 1.01 | 4.271 | 2.509 | 0.389 | 3.204 |
| Income Before Tax
| -66.903 | -137.35 | 51.272 | 2,784.286 | 3,191.931 | 105.758 | 70.329 | 87.341 | 52.582 | 53.782 | 33.557 | 3.932 |
| Income Before Tax Ratio
| -0.027 | -0.065 | 0.033 | 0.567 | 0.668 | 0.09 | 0.073 | 0.092 | 0.074 | 0.089 | 0.057 | 0.007 |
| Income Tax Expense
| 18.927 | -10.003 | -15.711 | 442.382 | 528.412 | 14.349 | 14.499 | 22.153 | 14.374 | 14.094 | 8.417 | 0.956 |
| Net Income
| -87.129 | -130.871 | 66.916 | 2,341.904 | 2,663.519 | 89.266 | 56.669 | 65.011 | 38.215 | 42.313 | 24.917 | 3.036 |
| Net Income Ratio
| -0.035 | -0.062 | 0.043 | 0.477 | 0.557 | 0.076 | 0.059 | 0.068 | 0.054 | 0.07 | 0.043 | 0.006 |
| EPS
| -0.22 | -0.34 | 0.17 | 6 | 6.83 | 0.23 | 0.45 | 0.22 | 0.16 | 0.36 | 0.22 | 0 |
| EPS Diluted
| -0.22 | -0.34 | 0.17 | 6 | 6.83 | 0.23 | 0.45 | 0.22 | 0.16 | 0.36 | 0.22 | 0 |
| EBITDA
| 176.728 | 86.581 | 202.543 | 2,867.717 | 3,326.171 | 170.852 | 118.254 | 130.11 | 68.224 | 67.496 | 67.33 | 43.701 |
| EBITDA Ratio
| 0.072 | 0.041 | 0.129 | 0.584 | 0.696 | 0.146 | 0.122 | 0.137 | 0.096 | 0.112 | 0.115 | 0.079 |